Skip to main content
OpenTrials
Completed

NCT Number: NCT04384250

Genetic and Immunologic Basis of COVID-19 Infection

We will study genetic factors causing severe disease due to infection with SARS-COV-2 which may help to find targeted therapy

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Genetic Basis of COVID-19 Infection

Age range

1 day–50 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Mansoura University

Al Mansurah, Dakahlyia, 35516, Egypt

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • severe COVID-19 infection

Exclusion criteria

  • Comorbidity ((DM, hypertension, Chronic liver or Kidney diseases, HIV, morbid obesity, Malignancy, Immunosuppressive therapy)

Treatment and study plan

Whole Exome Sequencing

Diagnostic Test

Genetic study of patients

Primary outcomes

  1. Mutations leading to increase susceptibility to SARS-COV-2 infection

    Time frame: 12 months

    Genetic susceptibility to COVID-19

Sponsors and collaborators

Lead sponsor

Mansoura University

Other

Registry information

Official study title

Genetic Factors Influencing the Response to Infection with SARS-COV-2

Important dates

Study start
2020
Primary completion
2023
Study completion
2024
First posted
May 12, 2020
Registry last updated
Mar 11, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.